Back to Journals » OncoTargets and Therapy » Volume 13

Polysaccharides Derived from Saposhnikovia divaricata May Suppress Breast Cancer Through Activating Macrophages

Authors Ding J, Guo Y, Jiang X, Li Q, Li K, Liu M, Fu W, Cao Y

Received 14 July 2020

Accepted for publication 18 September 2020

Published 22 October 2020 Volume 2020:13 Pages 10749—10757


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3

Editor who approved publication: Dr Yao Dai

Jingxian Ding,1,* Yonghong Guo,2,* Xiaoliu Jiang,1 Qingge Li,1 Kai Li,1 Min Liu,1 Wenbing Fu,1 Yali Cao3

1Department of Radiation Oncology, The Breast Cancer Institute, The Third Hospital of Nanchang, Nanchang, Jiangxi Province 330025, China; 2Department of Radiation Oncology, The Fourth Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330003, China; 3Department of Breast Surgery, The Breast Cancer Institute, The Third Hospital of Nanchang, Nanchang, Jiangxi Province 330025, China

*These authors contributed equally to this work

Correspondence: Jingxian Ding; Yali Cao Email;

Background: Saposhnikovia divaricata (SD) has been used in traditional Chinese medicine to treat pain, inflammation, and arthritis. Recently, it has been reported that SD extract may inhibit tumor growth, but the mechanism involved is elusive. The aim of this study was to investigate the anti-tumor activity of polysaccharides derived from SD in breast cancer and the underlying mechanisms.
Materials and Methods: Polysaccharides isolated from SD were analyzed using Fourier transform infrared (FT-IR) spectroscopy and gas chromatography-mass spectroscopy (GC-MS). Their effects on cell growth of U937, MCF-7, and MDA-MB-231, and tumor growth in a mouse MDA-MB 231 xenograft model were examined. Their role in U937 activation, MCF-7, and MDA-MB 231 cytokine release profiles were also tested.
Results: In vitro studies showed that SD polysaccharides (SDPs) promoted U937 cell growth dose-dependently, with no obvious effect on growth of breast cancer cell lines MCF-7 and MDA-MB-231. SDP also showed an antagonistic effect against the growth inhibition of U937 by the culture supernatants of MCF-7 and MDA-MB-231, and reversed the polarization status of U937. Treatment of SCID mice bearing MDA-MB-231-derived xenograft tumors with SDP significantly reduced tumor growth. At all tested concentrations, no obvious toxic side-effects were recorded.
Discussion: We tentatively concluded that SDPs potently promote the growth of U937 and activate it to inhibit the tumor growth of SCID mice bearing MDA-MB-231-derived xenograft tumors indirectly, with no obvious growth inhibition effects on MCF-7 and MDA-MB-231 in vitro. Our finding indicated that SDP could be a potential anticancer agent for breast cancer.

Keywords: breast cancer, Saposhnikovia divaricata, polysaccharides, immuno-regulation, macrophage

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]